Related Experiment Video
Updated: Jun 14, 2025

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
Complex Interplay between DNA Damage and Autophagy in Disease and Therapy
Aman Singh1, Naresh Ravendranathan1, Jefferson C Frisbee1
1Department of Medical Biophysics, Schulich School of Medicine and Dentistry, University of Western Ontario, 1151 Richmond Street North, London, ON N6A 5C1, Canada.
Abstract:
Cancer, a multifactorial disease characterized by uncontrolled cellular proliferation, remains a global health challenge with significant morbidity and mortality. Genomic and molecular aberrations, coupled with environmental factors, contribute to its heterogeneity and complexity. Chemotherapeutic agents like doxorubicin (Dox) have shown efficacy against various cancers but are hindered by dose-dependent cytotoxicity, particularly on vital organs like the heart and brain. Autophagy, a cellular process involved in self-degradation and recycling, emerges as a promising therapeutic target in cancer therapy and neurodegenerative diseases. Dysregulation of autophagy contributes to cancer progression and drug resistance, while its modulation holds the potential to enhance treatment outcomes and mitigate adverse effects. Additionally, emerging evidence suggests a potential link between autophagy, DNA damage, and caretaker breast cancer genes BRCA1/2, highlighting the interplay between DNA repair mechanisms and cellular homeostasis. This review explores the intricate relationship between cancer, Dox-induced cytotoxicity, autophagy modulation, and the potential implications of autophagy in DNA damage repair pathways, particularly in the context of BRCA1/2 mutations.
Insights
This review explores how modulating autophagy, a cellular recycling process, can enhance cancer therapy and reduce doxorubicin (Dox) side effects. It also examines autophagy's role in DNA repair, especially concerning BRCA1/2 mutations.
Area of Science:
- Oncology
- Cellular Biology
- Genetics
Background:
- Cancer is a complex disease driven by genetic and environmental factors.
- Doxorubicin (Dox) is an effective chemotherapy but causes dose-dependent toxicity.
- Autophagy, a cellular degradation process, is implicated in cancer and neurodegenerative diseases.
Purpose of the Study:
- To review the relationship between cancer, doxorubicin (Dox) toxicity, and autophagy modulation.
- To explore the role of autophagy in DNA damage repair pathways.
- To investigate the implications of autophagy in BRCA1/2-mutated cancers.
Main Methods:
- Literature review of existing research on cancer, autophagy, doxorubicin, and DNA repair.
- Analysis of the interplay between autophagy, DNA damage, and BRCA1/2 genes.
- Synthesis of evidence on therapeutic targeting of autophagy in cancer treatment.
Main Results:
- Autophagy dysregulation contributes to cancer progression and drug resistance.
- Modulating autophagy may enhance chemotherapy efficacy and reduce side effects.
- Autophagy is linked to DNA damage repair, with potential relevance to BRCA1/2 mutations.
Conclusions:
- Targeting autophagy presents a promising strategy for improving cancer therapy outcomes.
- Understanding autophagy's role in DNA repair could lead to novel therapeutic approaches for BRCA1/2-mutated cancers.
- Further research is needed to fully elucidate the therapeutic potential of autophagy modulation in oncology.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
DNA Damage can Stall the Cell Cycle
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of DNA Repair
Chemically...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
The Intrinsic Apoptotic Pathway

